83 FR 6725 - Qualification of Drivers; Exemption Applications; Diabetes Mellitus
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration Federal Register Volume 83, Issue 31 (February 14, 2018)
Federal Motor Carrier Safety Administration
Federal Register Volume 83, Issue 31 (February 14, 2018)
| Page Range | 6725-6729 | |
| FR Document | 2018-03068 |
[Federal Register Volume 83, Number 31 (Wednesday, February 14, 2018)] [Notices] [Pages 6725-6729] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-03068] ----------------------------------------------------------------------- DEPARTMENT OF TRANSPORTATION Federal Motor Carrier Safety Administration [Docket No. FMCSA-2017-0289] Qualification of Drivers; Exemption Applications; Diabetes Mellitus AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT. ACTION: Notice of applications for exemption; request for comments. ----------------------------------------------------------------------- SUMMARY: FMCSA announces receipt of applications from 26 individuals for an exemption from the prohibition in the Federal Motor Carrier Safety Regulations (FMCSRs) against persons with insulin-treated diabetes mellitus (ITDM) operating a commercial motor vehicle (CMV) in interstate commerce. If granted, the exemptions would enable these individuals with ITDM to operate CMVs in interstate commerce. DATES: Comments must be received on or before March 16, 2018. ADDRESSES: You may submit comments bearing the Federal Docket Management System (FDMS) Docket No. FMCSA-2017-0289 using any of the following methods:Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the online instructions for submitting comments. Mail: Docket Management Facility; U.S. Department of Transportation, 1200 New Jersey Avenue SE, West Building Ground Floor, Room W12-140, Washington, DC 20590-0001. Hand Delivery: West Building Ground Floor, Room W12-140, 1200 New Jersey Avenue SE, Washington, DC, between 9 a.m. and 5 p.m., ET, Monday through Friday, except Federal Holidays. Fax: 1-202-493-2251. Instructions: Each submission must include the Agency name and the docket number(s) for this notice. Note that all comments received will be posted without change to http://www.regulations.gov, including any personal information provided. Please see the Privacy Act heading below for further information. Docket: For access to the docket to read background documents or comments, go to http://www.regulations.gov at any time or Room W12-140 on the ground level of the West Building, 1200 New Jersey Avenue SE, Washington, DC, between 9 a.m. and 5 p.m., ET, Monday through Friday, except Federal holidays. The FDMS is available 24 hours each day ET, 365 days each year. If you want acknowledgment that we received your comments, please include a self-addressed, stamped envelope or postcard or print the acknowledgement page that appears after submitting comments online. Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits comments from the public to better inform its rulemaking process. DOT posts these comments, without edit, including any personal information the commenter provides, to http://www.regulations.gov, as described in the system of records notice (DOT/ALL-14 FDMS), which can be reviewed at http://www.dot.gov/privacy. FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, [email protected], FMCSA, Department of Transportation, 1200 New Jersey Avenue SE, Room W64-224, Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., ET, Monday through Friday, except Federal holidays. If you have questions regarding viewing or submitting material to the docket, contact Docket Services, telephone (202) 366-9826. SUPPLEMENTARY INFORMATION: I. Background Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption from the FMCSRs for a five-year period if it finds ``such exemption would likely achieve a level of safety that is equivalent to or greater than the level that would be achieved absent such exemption.'' The statute also allows the Agency to renew exemptions at the end of the five-year period. FMCSA grants [[Page 6726]] exemptions from the FMCSRs for a two-year period to align with the maximum duration of a driver's medical certification. The 26 individuals listed in this notice have requested an exemption from the diabetes prohibition in 49 CFR 391.41(b)(3). Accordingly, the Agency will evaluate the qualifications of each applicant to determine whether granting the exemption will achieve the required level of safety mandated by statute. The physical qualification standard for drivers regarding diabetes found in 49 CFR 391.41(b)(3) states that a person is physically qualified to drive a CMV if that person has no established medical history or clinical diagnosis of diabetes mellitus currently requiring insulin for control. The Agency established the current requirement for diabetes in 1970 because several risk studies indicated that drivers with diabetes had a higher rate of crash involvement than the general population. FMCSA established its diabetes exemption program, based on the Agency's July 2000 study entitled ``A Report to Congress on the Feasibility of a Program to Qualify Individuals with Insulin-Treated Diabetes Mellitus to Operate in Interstate Commerce as Directed by the Transportation Act for the 21st Century.'' The report concluded that a safe and practicable protocol to allow some drivers with ITDM to operate CMVs is feasible. The September 3, 2003 (68 FR 52441), Federal Register notice in conjunction with the November 8, 2005 (70 FR 67777), Federal Register notice provides the current protocol for allowing such drivers to operate CMVs in interstate commerce. FMCSA notes that section 4129 of the Safe, Accountable, Flexible and Efficient Transportation Equity Act: A Legacy for Users requires the Secretary to revise its diabetes exemption program established on September 3, 2003 (68 FR 52441). The revision must provide for individual assessment of drivers with diabetes mellitus, and be consistent with the criteria described in section 4018 of the Transportation Equity Act for the 21st Century (49 U.S.C. 31305). Section 4129 requires: (1) Elimination of the requirement for three years of experience operating CMVs while being treated with insulin; and (2) establishment of a specified minimum period of insulin use to demonstrate stable control of diabetes before being allowed to operate a CMV. In response to section 4129, FMCSA made immediate revisions to the diabetes exemption program established by the September 3, 2003 notice. FMCSA discontinued use of the three-year driving experience and fulfilled the requirements of section 4129 while continuing to ensure that operation of CMVs by drivers with ITDM will achieve the requisite level of safety required of all exemptions granted under 49 U.S.C. 31136 (e). Section 4129(d) also directed FMCSA to ensure that drivers of CMVs with ITDM are not held to a higher standard than other drivers, with the exception of limited operating, monitoring and medical requirements that are deemed medically necessary. The FMCSA concluded that all of the operating, monitoring and medical requirements set out in the September 3, 2003, notice, except as modified, were in compliance with section 4129(d). Therefore, all of the requirements set out in the September 3, 2003, notice, except as modified by the notice in the Federal Register on November 8, 2005 (70 FR 67777), remain in effect. II. Qualifications of Applicants David V. Bartel Mr. Bartel, 47, has had ITDM since 2014. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Bartel understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Bartel meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Minnesota. Michael Brady Mr. Brady, 67, has had ITDM since 2014. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Brady understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Brady meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from New Hampshire. Junior K. Brewer Mr. Brewer, 67, has had ITDM since 2011. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Brewer understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Brewer meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Nebraska. Marvin D. Buitt Mr. Buitt, 45, has had ITDM since 2015. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Buitt understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Buitt meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Mississippi. Larry E. Burchett Mr. Burchett, 69, has had ITDM since 2013. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Burchett understands diabetes management and monitoring, [[Page 6727]] has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Burchett meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Florida. Pasquale Cala Mr. Cala, 41, has had ITDM since 2000. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Cala understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Cala meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Pennsylvania. Byron D. Christian Mr. Christian, 61, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Christian understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Christian meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Louisiana. Bryon D. Cowell Mr. Cowell, 50, has had ITDM since 2011. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Cowell understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Cowell meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Iowa. Walter B. Cromwell, 3rd Mr. Cromwell, 49, has had ITDM since 2000. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Cromwell understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Cromwell meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from New Jersey. Eric C. Delio Mr. Delio, 46, has had ITDM since 2005. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Delio understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Delio meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Indiana. Wade A. Demarais Mr. Demarais, 42, has had ITDM since 2000. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Demarais understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Demarais meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Minnesota. Gary D. Detwiler Mr. Detwiler, 28, has had ITDM since 2014. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Detwiler understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Detwiler meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from California. Willis L. Drake, Jr. Mr. Drake, 57, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Drake understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Drake meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Maryland. Doyle J. Dreisow Mr. Dreisow, 53, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or [[Page 6728]] resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Dreisow understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Dreisow meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Wisconsin. Anthony Episcopo Mr. Episcopo, 46, has had ITDM since 2017. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Episcopo understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Episcopo meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds an operator's license from Wisconsin. Herve H. Estime Mr. Estime, 43, has had ITDM since 2013. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Estime understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Estime meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Georgia. Gregory A. Gruber Mr. Gruber, 64, has had ITDM since 2015. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Gruber understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Gruber meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Kansas. Clifford J. Hughes Mr. Hughes, 64, has had ITDM since 2012. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Hughes understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Hughes meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from New York. Brian J. Lanzim Mr. Lanzim, 28, has had ITDM since 2015. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Lanzim understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Lanzim meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from New Jersey. Michael E. Luttrell Mr. Luttrell, 53, has had ITDM since 2017. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Luttrell understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Luttrell meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Georgia. William R. Mizell Mr. Mizell, 62, has had ITDM since 2008. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Mizell understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Mizell meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Arkansas. Frank E. Myers, Jr. Mr. Myers, 52, has had ITDM since 2017. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Myers understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Myers meets the requirements of the vision standard at [[Page 6729]] 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Oklahoma. John W. Olenczak Mr. Olenczak, 75, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Olenczak understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Olenczak meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from New Jersey. Michael A. Randazzo Mr. Randazzo, 28, has had ITDM since 2013. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Randazzo understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Randazzo meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Pennsylvania. Jonathan M. Trussell Mr. Trussell, 30, has had ITDM since 2010. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Trussell understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Trussell meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Texas. Raymond L. Underwood, Jr. Mr. Underwood, 64, has had ITDM since 2006. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (two or more) severe hypoglycemic episodes in the last five years. His endocrinologist certifies that Mr. Underwood understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Underwood meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable proliferative diabetic retinopathy. He holds an operator's license from Connecticut. III. Request for Comments In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests public comment from all interested persons on the exemption petitions described in this notice. We will consider all comments received before the close of business on the closing date indicated in the dates section of the notice. IV. Submitting Comments You may submit your comments and material online or by fax, mail, or hand delivery, but please use only one of these means. FMCSA recommends that you include your name and a mailing address, an email address, or a phone number in the body of your document so that FMCSA can contact you if there are questions regarding your submission. To submit your comment online, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2017-0289 and click the search button. When the new screen appears, click on the blue ``Comment Now!'' button on the right hand side of the page. On the new page, enter information required including the specific section of this document to which each comment applies, and provide a reason for each suggestion or recommendation. If you submit your comments by mail or hand delivery, submit them in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for copying and electronic filing. If you submit comments by mail and would like to know that they reached the facility, please enclose a stamped, self-addressed postcard or envelope. We will consider all comments and materials received during the comment period. FMCSA may issue a final determination at any time after the close of the comment period. V. Viewing Comments and Documents To view comments, as well as any documents mentioned in this preamble, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2017-0289 and click ``Search.'' Next, click ``Open Docket Folder'' and you will find all documents and comments related to this notice. Issued on: February 7, 2018. Larry W. Minor, Associate Administrator for Policy. [FR Doc. 2018-03068 Filed 2-13-18; 8:45 am] BILLING CODE 4910-EX-P
![Federal Register / Vol. 83, No. 31 / Wednesday, February 14, 2018 / Notices 6725
Richard W. Winters (CA) Rick English (OH) New Jersey Avenue SE, Washington,
Steven G. Wiskes (WI) Floyd T. Hall (AK) DC, between 9 a.m. and 5 p.m., ET,
The following five applicants did not Jeffery H. Hopper (IN) Monday through Friday, except Federal
have sufficient driving experience James M. Lewis (GA) Holidays.
Christopher J. Neville (ME) • Fax: 1–202–493–2251.
during the past three years under Michael R. O’Connor (NC)
normal highway operating conditions Instructions: Each submission must
Azusa Okajima (HI) include the Agency name and the
(gaps in driving record): Michael L. Parsons (NY)
docket number(s) for this notice. Note
Hope A. Bennett (PA) Gerardp Reyes Hernandez (CA)
Edwin J. Rojas (FL) that all comments received will be
Jeffrey T. Molosz (IL)
posted without change to http://
Charles J. Pukis (IN) The following five applicants perform
Gustavo Quintero (NJ) www.regulations.gov, including any
transportation for the Federal
Pedro T. Tellez Alvarez (CA) personal information provided. Please
government, state, or any political sub-
see the Privacy Act heading below for
The following 16 applicants were division of the state:
further information.
denied for multiple reasons: Fabio E. Cordero (GA) Docket: For access to the docket to
Rickey J. Adams (GA) Dennis S. Morgan (AZ) read background documents or
James W. Boyde (AL) Norberto Santiago (CT)
comments, go to http://
David S. Brown (PA) Gerald L. Wheeler (FL)
Michael Wideman (IL) www.regulations.gov at any time or
Gary R. Cowie (MI) Room W12–140 on the ground level of
Juliana M. Davis (CA) Issued on: February 7, 2018. the West Building, 1200 New Jersey
Luis Duval (NJ) Larry W. Minor, Avenue SE, Washington, DC, between 9
Joel E. Fevold (IA) Associate Administrator for Policy. a.m. and 5 p.m., ET, Monday through
Kevin E. Hickerson (CA) [FR Doc. 2018–03054 Filed 2–13–18; 8:45 am] Friday, except Federal holidays. The
Johnny M. Kruprzak (OH) BILLING CODE 4910–EX–P FDMS is available 24 hours each day
Walter H. Matthews (VA) ET, 365 days each year. If you want
Rory S. Milam (WV) acknowledgment that we received your
Gregory T. Rappe (IN) DEPARTMENT OF TRANSPORTATION comments, please include a self-
Robert E. Schmidt (CO) addressed, stamped envelope or
Oscar A. Sosa (CA) Federal Motor Carrier Safety postcard or print the acknowledgement
Al D. Swiney (LA) Administration page that appears after submitting
Daniel A. Wilson (IN) comments online.
[Docket No. FMCSA–2017–0289]
The following three applicants have Privacy Act: In accordance with 5
not had stable vision for the preceding Qualification of Drivers; Exemption U.S.C. 553(c), DOT solicits comments
three-year period: Ronald S. Berneking, Applications; Diabetes Mellitus from the public to better inform its
(MN); Alexander Vaughn, (FL); Brandon rulemaking process. DOT posts these
L. Younkin, (WY). AGENCY: Federal Motor Carrier Safety
comments, without edit, including any
The following 14 applicants met the Administration (FMCSA), DOT.
personal information the commenter
current federal vision standards. ACTION: Notice of applications for provides, to http://www.regulations.gov,
Exemptions are not required for exemption; request for comments. as described in the system of records
applicants who meet the current SUMMARY: FMCSA announces receipt of notice (DOT/ALL–14 FDMS), which can
regulations for vision: applications from 26 individuals for an be reviewed at http://www.dot.gov/
Teodula Alba (TX) exemption from the prohibition in the privacy.
Dexter M. Byrd (AL) Federal Motor Carrier Safety FOR FURTHER INFORMATION CONTACT: Ms.
Richard H. Harnden (NH) Regulations (FMCSRs) against persons Christine A. Hydock, Chief, Medical
Yahan C. Hernandez-Ramirez (NM) with insulin-treated diabetes mellitus Programs Division, (202) 366–4001,
Robert E. Hill (WA) (ITDM) operating a commercial motor fmcsamedical@dot.gov, FMCSA,
Tami J. Jackson (WA) vehicle (CMV) in interstate commerce. If Department of Transportation, 1200
Charles W. Kelly (AR) granted, the exemptions would enable New Jersey Avenue SE, Room W64–224,
Lee A. Litton (IN) these individuals with ITDM to operate Washington, DC 20590–0001. Office
Terence E. Michel (CO) CMVs in interstate commerce. hours are 8:30 a.m. to 5 p.m., ET,
Peter A. Novak (ND) DATES: Comments must be received on Monday through Friday, except Federal
Raimer A. Paredes-Escano (NJ) holidays. If you have questions
or before March 16, 2018.
Daniel J. Wallace (NM) regarding viewing or submitting
ADDRESSES: You may submit comments
Alex J. Wittman (PA) material to the docket, contact Docket
Timothy K. Wood (CA) bearing the Federal Docket Management
System (FDMS) Docket No. FMCSA– Services, telephone (202) 366–9826.
The following applicant drove 2017–0289 using any of the following SUPPLEMENTARY INFORMATION:
interstate while restricted to intrastate methods:
driving: William Perez, (TX). I. Background
• Federal eRulemaking Portal: Go to
The following 16 applicants will not http://www.regulations.gov. Follow the Under 49 U.S.C. 31136(e) and 31315,
be driving interstate, interstate online instructions for submitting FMCSA may grant an exemption from
commerce, or are not required to carry comments. the FMCSRs for a five-year period if it
daltland on DSKBBV9HB2PROD with NOTICES
a DOT medical card: • Mail: Docket Management Facility; finds ‘‘such exemption would likely
Marco A. Alvarez (CA) U.S. Department of Transportation, 1200 achieve a level of safety that is
Herbert G. Banham, III (MD) New Jersey Avenue SE, West Building equivalent to or greater than the level
Athanasios D. Brotsis (GA) Ground Floor, Room W12–140, that would be achieved absent such
Amanda J. Darling (IL) Washington, DC 20590–0001. exemption.’’ The statute also allows the
William E. Dennison, V (IN) • Hand Delivery: West Building Agency to renew exemptions at the end
David E. Dickinson (CA) Ground Floor, Room W12–140, 1200 of the five-year period. FMCSA grants
VerDate Sep<11>2014 22:07 Feb 13, 2018 Jkt 244001 PO 00000 Frm 00219 Fmt 4703 Sfmt 4703 E:\FR\FM\14FEN1.SGM 14FEN1](https://thefederalregister.org/doc/83_FR_6756/page/1.svg)
![Federal Register / Vol. 83, No. 31 / Wednesday, February 14, 2018 / Notices 6729
49 CFR 391.41(b)(10). His optometrist insulin, and is able to drive a CMV submit them in an unbound format, no
examined him in 2017 and certified that safely. Mr. Trussell meets the larger than 81⁄2 by 11 inches, suitable for
he does not have diabetic retinopathy. requirements of the vision standard at copying and electronic filing. If you
He holds a Class B CDL from Oklahoma. 49 CFR 391.41(b)(10). His optometrist submit comments by mail and would
examined him in 2017 and certified that like to know that they reached the
John W. Olenczak
he does not have diabetic retinopathy. facility, please enclose a stamped, self-
Mr. Olenczak, 75, has had ITDM since He holds a Class A CDL from Texas. addressed postcard or envelope.
2016. His endocrinologist examined him We will consider all comments and
in 2017 and certified that he has had no Raymond L. Underwood, Jr.
materials received during the comment
severe hypoglycemic reactions resulting Mr. Underwood, 64, has had ITDM period. FMCSA may issue a final
in loss of consciousness, requiring the since 2006. His endocrinologist determination at any time after the close
assistance of another person, or examined him in 2017 and certified that of the comment period.
resulting in impaired cognitive function he has had no severe hypoglycemic
that occurred without warning in the reactions resulting in loss of V. Viewing Comments and Documents
past 12 months and no recurrent (two or consciousness, requiring the assistance To view comments, as well as any
more) severe hypoglycemic episodes in of another person, or resulting in documents mentioned in this preamble,
the last five years. His endocrinologist impaired cognitive function that go to http://www.regulations.gov and in
certifies that Mr. Olenczak understands occurred without warning in the past 12 the search box insert the docket number
diabetes management and monitoring, months and no recurrent (two or more) FMCSA–2017–0289 and click ‘‘Search.’’
has stable control of his diabetes using severe hypoglycemic episodes in the Next, click ‘‘Open Docket Folder’’ and
insulin, and is able to drive a CMV last five years. His endocrinologist you will find all documents and
safely. Mr. Olenczak meets the certifies that Mr. Underwood comments related to this notice.
requirements of the vision standard at understands diabetes management and
Issued on: February 7, 2018.
49 CFR 391.41(b)(10). His optometrist monitoring, has stable control of his
examined him in 2017 and certified that diabetes using insulin, and is able to Larry W. Minor,
he does not have diabetic retinopathy. drive a CMV safely. Mr. Underwood Associate Administrator for Policy.
He holds a Class A CDL from New meets the requirements of the vision [FR Doc. 2018–03068 Filed 2–13–18; 8:45 am]
Jersey. standard at 49 CFR 391.41(b)(10). His BILLING CODE 4910–EX–P
Michael A. Randazzo ophthalmologist examined him in 2017
and certified that he has stable
Mr. Randazzo, 28, has had ITDM proliferative diabetic retinopathy. He DEPARTMENT OF TRANSPORTATION
since 2013. His endocrinologist holds an operator’s license from
examined him in 2017 and certified that Connecticut. Federal Motor Carrier Safety
he has had no severe hypoglycemic Administration
reactions resulting in loss of III. Request for Comments
[Docket No. FMCSA–2011–0389; FMCSA–
consciousness, requiring the assistance In accordance with 49 U.S.C. 31136(e) 2012–0094; FMCSA–2013–0107; FMCSA–
of another person, or resulting in and 31315, FMCSA requests public 2014–0381; FMCSA–2015–0116]
impaired cognitive function that comment from all interested persons on
occurred without warning in the past 12 the exemption petitions described in Qualification of Drivers; Exemption
months and no recurrent (two or more) this notice. We will consider all Applications; Epilepsy and Seizure
severe hypoglycemic episodes in the comments received before the close of Disorders
last five years. His endocrinologist business on the closing date indicated AGENCY: Federal Motor Carrier Safety
certifies that Mr. Randazzo understands in the dates section of the notice. Administration (FMCSA), DOT.
diabetes management and monitoring,
has stable control of his diabetes using IV. Submitting Comments ACTION: Notice of final disposition.
insulin, and is able to drive a CMV You may submit your comments and
SUMMARY: FMCSA announces its
safely. Mr. Randazzo meets the material online or by fax, mail, or hand
decision to renew exemptions for six
requirements of the vision standard at delivery, but please use only one of
individuals from the requirement in the
49 CFR 391.41(b)(10). His optometrist these means. FMCSA recommends that
Federal Motor Carrier Safety
examined him in 2017 and certified that you include your name and a mailing
Regulations (FMCSRs) that interstate
he does not have diabetic retinopathy. address, an email address, or a phone
commercial motor vehicle (CMV)
He holds an operator’s license from number in the body of your document
drivers have ‘‘no established medical
Pennsylvania. so that FMCSA can contact you if there
history or clinical diagnosis of epilepsy
are questions regarding your
Jonathan M. Trussell or any other condition which is likely
submission.
Mr. Trussell, 30, has had ITDM since To submit your comment online, go to to cause loss of consciousness or any
2010. His endocrinologist examined him http://www.regulations.gov and in the loss of ability to control a CMV.’’ The
in 2017 and certified that he has had no search box insert the docket number exemptions enable these individuals
severe hypoglycemic reactions resulting FMCSA–2017–0289 and click the search who have had one or more seizures and
in loss of consciousness, requiring the button. When the new screen appears, are taking anti-seizure medication to
assistance of another person, or click on the blue ‘‘Comment Now!’’ continue to operate CMVs in interstate
resulting in impaired cognitive function button on the right hand side of the commerce.
daltland on DSKBBV9HB2PROD with NOTICES
that occurred without warning in the page. On the new page, enter DATES: The exemptions were applicable
past 12 months and no recurrent (two or information required including the on November 6, 2017. The exemptions
more) severe hypoglycemic episodes in specific section of this document to expire on November 6, 2019.
the last five years. His endocrinologist which each comment applies, and FOR FURTHER INFORMATION CONTACT: Ms.
certifies that Mr. Trussell understands provide a reason for each suggestion or Christine A. Hydock, Chief, Medical
diabetes management and monitoring, recommendation. If you submit your Programs Division, (202) 366–4001,
has stable control of his diabetes using comments by mail or hand delivery, fmcsamedical@dot.gov, FMCSA,
VerDate Sep<11>2014 22:07 Feb 13, 2018 Jkt 244001 PO 00000 Frm 00223 Fmt 4703 Sfmt 4703 E:\FR\FM\14FEN1.SGM 14FEN1](https://thefederalregister.org/doc/83_FR_6756/page/5.svg)
Document Created: 2018-02-14 03:58:57
Document Modified: 2018-02-14 03:58:57
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of applications for exemption; request for comments. | |
| Dates | Comments must be received on or before March 16, 2018. | |
| Contact | Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, [email protected], FMCSA, Department of Transportation, 1200 New Jersey Avenue SE, Room W64-224, Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., ET, Monday through Friday, except Federal holidays. If you have questions regarding viewing or submitting material to the docket, contact Docket Services, telephone (202) 366-9826. | |
| FR Citation | 83 FR 6725 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR